Renaissance Capital logo

ZyVersa Therapeutics (Larkspur Health Acquisition)

Priced, Nasdaq: ZVSA

Blank check company focused on the US biotechnology sector (completed 12/12/2022).

Industry: SPAC

First Day Return: -0.2%

We are a newly-organized blank check company incorporated in Delaware. While our efforts to identify a target business may span many industries and regions worldwide, we intend to focus our search for prospects within the biotechnology sector in the United States. Our management team is led by Daniel O’Connor, our Chairman and CEO, and David Briones, our CFO and Secretary. Daniel O’Connor is founder and the manager of our sponsor, Larkspur Health.
IPO Data
IPO Date 12/20/2021
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $75
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Bridgewater, NJ, United States
Founded 2021
Employees at IPO 2

ZyVersa Therapeutics (Larkspur Health Acquisition) (ZVSA) Performance